Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: Analysis of biomarker release

Europace

Volumn 16, Issue 7, 2014, Pages 987-993

  Bordignon, Stefano ^a   Fürnkranz, Alexander ^a   Dugo, Daniela ^a   Perrotta, Laura ^a   Gunawardene, Melanie ^a   Bode, Frank ^b   Klemt, Anne ^a   Nowak, Bernd ^a   Schulte Hahn, Britta ^a   Schmidt, Boris ^a   Chun, K R Julian ^a  

^a CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Atrial fibrillation; Cardiac biomarker; Cryoablation

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; TROPONIN T; BIOLOGICAL MARKER;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; BALLOON CATHETER; CARDIAC MAPPING SYSTEM; CATHETER ABLATION; CATHETER SHEATH; CRYOABLATION; CRYOBALLOON ABLATION; CRYOBALLOON CATHETER; FEMALE; FOLLOW UP; GUIDE WIRE; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; NERVE PARALYSIS; OUTCOME ASSESSMENT; PHRENIC NERVE; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; AGED; ATRIAL FIBRILLATION; BLOOD; COMPARATIVE STUDY; CRYOSURGERY; EQUIPMENT DESIGN; HEART CATHETER; OPERATION DURATION; PATHOPHYSIOLOGY; PULMONARY VEIN; TIME; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIAC CATHETERS; CREATINE KINASE; CRYOSURGERY; EQUIPMENT DESIGN; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; OPERATIVE TIME; PULMONARY VEINS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84903984617     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut400     Document Type: Article

References (36)

1. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413
2. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606
3. Fürnkranz A, Chun KRJ, Nuyens D, Metzner A, Köster I, Schmidt B et al. Characterization of conduction recovery after pulmonary vein isolation using the 'single big cryoballoon' technique. Heart Rhythm 2010;7:184-90
4. Chun KRJ, Fürnkranz A, Köster I, MetznerA, Tönnis T, Wohlmuth P et al.Twoversus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: The ALSTER EXTRA Pilot Study. J Cardiovasc Electrophysiol 2012;23:814-9
5. Chun KRJ, Fürnkranz A, Metzner A, Schmidt B, Tilz R, Zerm Tet al. Cryoballoon pulmonary vein isolation with real-time recordings from the pulmonary veins. J Cardiovasc Electrophysiol 2009;20:1203-10
6. Chun KJ, Bordignon S, Gunawardene M, Urban V, Kulikoglu M, Schulte-Hahn B et al. Single transseptal big cryoballoon pulmonary vein isolation using a novel inner lumen mapping catheter. Pacing Clin Electrophysiol 2012;35:1304-11
7. Dorwarth U, Schmidt M, Wankerl M, Krieg J, Straube F, Hoffmann E. Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol 2011;32:205-11
8. Madrid AH, del Rey JM, RubíJ, Ortega J, González Rebollo JM, Seara JG et al. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: Approach to size of necrosis. Am Heart J 1998;136:948-55
9. Katritsis DG, Hossein-Nia M, Anastasakis A, Poloniecki J, HoltDW, Camm AJ et al. Myocardial injury induced by radiofrequency and low energy ablation: A quantitative study of CKisoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998;21:1410-6
10. del Rey JM, Madrid AH, Valin?o JM, Rubí J, Mercader J, MoroCet al. Cardiac troponin I and minor cardiac damage: Biochemical markers in a clinical model of myocardial lesions. Clin Chem 1998;44:2270-6
11. ManolisAS, VassilikosV, MaounisT, Melita-ManolisH, Psarros L, HaliasosAet al. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: Procedural correlates. J AmColl Cardiol 1999;34:1099-105
12. Carlsson J, Erdogan A, Guettler N, Schulte B, Lay D, Neuzner J et al. Myocardial injury during radiofrequency catheter ablation: Comparison of focal and linear lesions. Pacing Clin Electrophysiol 2001;24:962-8
13. Hirose H, Kato K, Suzuki O, YoshidaT, Oguri M, YajimaKet al. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol 2006;16:169-74
14. Emkanjoo Z, Mottadayen M, Givtaj N, Alasti M, Arya A, HaghjooMet al. Evaluation of post-radiofrequency myocardial injury by measuring cardiac troponin I levels. Int J Cardiol 2007;117:173-7
15. Pudil R, Parízek P, Tichý M, Haman L, Horá ková L, Ulrychová M et al. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation. Clin Chem Lab Med 2008;46:1726-8
16. Matiello M, Mont L, Tamborero D, Berruezo A, Benito B, Gonzalez E et al. Cooledtip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: Comparison of efficacy, safety, and lesion extension. Europace 2008;10:955-60
17. Haegeli LM, Kotschet E, Byrne J, Adam DC, Lockwood EE, Leather RA et al. Cardiac injury after percutaneous catheter ablation for atrial fibrillation. Europace 2008;10: 273-5
18. Oswald H, Gardiwal A, LisselC, YuH, Klein G. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol 2007;30:885-90
19. Kühne M, Suter Y, Altmann D, Ammann P, Schaer B, Osswald S et al. Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: Biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. Heart Rhythm 2010;7:1770-6
20. Malmborg H, Christersson C, Lo?nnerholm S, Blomstro?m-Lundqvist C. Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation Europace 2013;15:798-804
21. Wó jcik M, Janin S, Neumann T, Kuniss M, Berkowitsch A, Erkapic D et al. Which standard biomarkers are useful for the evaluation of myocardial injury after pulmonary vein isolation with cryoballoon?. Kardiol Pol 2011;69:1151-5
22. Schmidt M, Marschang H, Clifford S, Harald R, Guido R, Oliver T et al. Trends in inflammatory biomarkers during atrial fibrillation ablation across different catheter ablation strategies. Int J Cardiol 2012;158:33-8
23. Herrera Siklódy C, Arentz T, Minners J, Jesel L, Stratz C, Valina CM et al. Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: A randomized study comparing radiofrequency ablation with cryoablation. Heart Rhythm 2012;9:189-96
24. Fürnkranz A, Bordignon S, Schmidt B, Gunawardene M, Schulte-Hahn B, Urban V et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol 2013;24:492-7
25. Neumann T, Vogt J, Schumacher B, Dorszewski A, KunissM, NeuserHet al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008;52:273-8
26. Bordignon S, Fürnkranz A, Schmidt B, Chun KJ. Remaining ice cap on secondgeneration cryoballoon after deflation. Circ Arrhythm Electrophysiol 2012;5:e98-9
27. Ahmed H, Neuzil P, Skoda J, D'Avila A, Donaldson DM, LaragyMCet al. The permanency of pulmonary vein isolation using a balloon cryoablation catheter. J Cardiovasc Electrophysiol 2010;21:731-7
28. Schmidt M, Dorwarth U, Straube F, Wankerl M, Krieg J, Leber AW et al. A novel double cryoballoon strategy in persistent atrial fibrillation: A pilot study. Clin Res Cardiol 2012;101:777-85
29. Chun KRJ, Fürnkranz A, Schmidt B, Metzner A, Tilz R, Zerm T et al. Right ventricular rapid pacing in catheter ablation of atrial fibrillation: A novel application for cryoballoon pulmonary vein isolation. Clin Res Cardiol 2009;98:493-500
30. Khairy P, Dubuc M. Transcatheter cryoablation part I: Preclinical experience. Pacing Clin Electrophysiol 2008;31:112-20
31. Bordignon S, Chun K-RJ, Gunawardene M, Urban V, Kulikoglu M, Miehm K et al. Energy titration strategies with the endoscopic ablation system: Lessons from the high-dose vs. low-dose laser ablation study. Europace 2012;15:685-9
32. StevenD, Sultan A, Reddy V, Lueker J, Altenburg M, Hoffmann B et al. Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: Results from a prospective two-center randomized trial. J Am Coll Cardiol 2013;62:44-50
33. Fürnkranz A, Bordignon S, Schmidt B, Böhmig M, Böhmer M-C, Bode F et al. Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm 2013;10:789-93
34. Andrade JG, Dubuc M, Guerra PG, Landry E, Coulombe N, LeducHet al. Pulmonary vein isolation using a second generation cryoballoon catheter: A randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol 2013;24:692-8
35. Casado-Arroyo R, Chierchia G-B, Conte G, Levinstein M, Sieira J, Rodriguez-Mañero M et al. Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: A comparison between the first- And second-generation balloon. Heart Rhythm 2013;10:1318-24
36. Ghosh J, Sepahpour A, Chan KH, Singarayar S, McGuire MA. Immediate balloon deflation for prevention of persistent phrenic nerve palsy during pulmonary vein isolation by balloon cryoablation. Heart Rhythm 2013;10:646-52